Haw ParHAWPF 95 Quick Ratio is 51.98 as of Dec. 2025, which is 22% above its 10-year median of 42.62. GuruFocus rates HAWPF with a GF Score™ of 95/100 and a GF Value™ of $8.79. The stock has 3 warning signs investors should review. Among 997 Drug Manufacturers companies, Haw Par ranks better than 99.5% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Haw Par's quick ratio for the quarter that ended in Dec. 2025 was 51.98.
Haw Par has a quick ratio of 51.98. It generally indicates good short-term financial strength.
The historical rank and industry rank for Haw Par's Quick Ratio or its related term are showing as below:
HAWPF'
s Quick Ratio Range Over the Past 10 Years
Min: 21.63 Med: 42.62 Max: 51.98
Current: 51.98
During the past 13 years, Haw Par's highest Quick Ratio was 51.98. The lowest was 21.63. And the median was 42.62.
HAWPF's Quick Ratio is ranked better than 99.5% of 997
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs HAWPF: 51.98
Haw Par (OTCPK:HAWPF) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Haw Par Quick Ratio Related Terms
Haw Par Quick Ratio Historical Data
* Premium members only.
The historical data trend for Haw Par's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Haw Par's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haw Par Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Haw Par's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Haw Par's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Haw Par's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haw Par (HAWPF) has a Quick Ratio of 51.98 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Haw Par and its competitors. This is 22% above median its historical median of 42.62. Over the past decade, Haw Par's Quick Ratio has ranged from 21.63 to 51.98. According to the industry distribution chart, Haw Par ranks #5 out of 997 companies in the Drug Manufacturers industry, placing it in the top 0.5%.
Is Haw Par's Quick Ratio too high?
Haw Par's current Quick Ratio of 51.98 is 22% above median its 10-year median of 42.62. Over the past 10 years, this metric has ranged from a low of 21.63 to a high of 51.98. The Drug Manufacturers industry median Quick Ratio is 1.45. Haw Par's value of 51.98 is 3484.8% above this industry median. Based on the distribution chart, Haw Par ranks #5 out of 997 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Haw Par has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does Haw Par's Quick Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Haw Par ranks #5 out of 997 companies for Quick Ratio. This places Haw Par in the top 1% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.45. Haw Par's value of 51.98 is 3484.8% above this benchmark. Historically, Haw Par's own Quick Ratio has ranged from 21.63 to 51.98 over the past decade. While the company's 10-year median is 42.62 vs. the industry median of 1.45, Haw Par has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 997 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Haw Par's current Quick Ratio of 51.98 is 3484.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Haw Par and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Haw Par's current Quick Ratio is 51.98, which is 22% above median its own 10-year median of 42.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haw Par stock overvalued right now?
Haw Par (HAWPF) has a current Quick Ratio of 51.98. The stock's GF Value™ is $8.79, compared to a current price of $12.00 — trading 36.5% above its estimated fair value. The current Quick Ratio is 51.98, which is 22% above median its 10-year median of 42.62 and 3484.8% above the Drug Manufacturers industry median of 1.45. Haw Par's overall GF Score™ is 95/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Haw Par (HAWPF), the current Quick Ratio is 51.98 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Haw Par (HAWPF) Overvalued in 2026?
Based on GuruFocus' analysis, Haw Par stock appears to be overvalued.
The current stock price of $12.00 is trading 36.5% above its estimated GF Value™ of $8.79.
Key valuation signals for HAWPF:
Quick Ratio: 51.98 (22% above median its 10-year median of 42.62)
GF Value™: $8.79 vs. price of $12.00 (36.5% above fair value)
Industry Position: 3484.8% above the Drug Manufacturers median (#5 of 997)
No single metric tells the full story. See the HAWPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Haw Par Corp Ltd is a drug manufacturing company that operates multiple brands. The company is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions. Its operating segments include the Healthcare segment, Investments segment, Property segment, and Leisure segment. The company generates the majority of its revenue from the Healthcare segment. Its Healthcare segment manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands. Geographically, it generates key revenue from the other ASEAN and other Asian countries.
95GF Score
Get the complete analysis for HAWPF
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAWPF has been successfully added to your 
